Literature DB >> 17923863

Maintaining immunological tolerance with Foxp3.

Lauren E Mays1, Youhai H Chen.   

Abstract

Central tolerance in the thymus is the primary mechanism for deleting autoreactive T cells. Despite this, escape of self-reactive T lymphocytes into the periphery reveals the threat of autoimmunity. To compensate for its imperfection, the thymus also produces a naturally occurring subset of Foxp3+ CD4+ CD25+ regulatory T cells with suppressive function, capable of controlling autoreactive cells. Foxp3 (forkhead box P3), the lineage-specific marker for this subset of cells, is crucial to their thymic development and peripheral function, and yet the transcriptional program driven by Foxp3 was until now largely undefined. Emerging evidence has provided insight into its role: from the ability of Foxp3 to cooperate with other transcription factors such as NFAT, to the genome-wide characterization of target genes directly bound and regulated by Foxp3. Here we discuss the discovery of naturally occurring regulatory T cells - their phenotype, development, maintenance, and function - largely as they are defined by the lineage-specific marker, Foxp3.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17923863     DOI: 10.1038/cr.2007.84

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  6 in total

Review 1.  Are increased Foxp3+ regulatory T cells responsible for immunosuppression during HTLV-1 infection? Case reports and review of the literature.

Authors:  Nicolas Barros; Fernando Woll; Luis Watanabe; Martin Montes
Journal:  BMJ Case Rep       Date:  2012-11-27

Review 2.  T regulatory cells in B-cell malignancy - tumour support or kiss of death?

Authors:  Camilla A Lindqvist; Angelica S I Loskog
Journal:  Immunology       Date:  2012-04       Impact factor: 7.397

3.  The human "Treg MLR": immune monitoring for FOXP3+ T regulatory cell generation.

Authors:  Josh Levitsky; Joshua Miller; Joseph Leventhal; Xuemei Huang; Cathy Flaa; Edward Wang; Anat Tambur; Richard K Burt; Lorenzo Gallon; James M Mathew
Journal:  Transplantation       Date:  2009-12-15       Impact factor: 4.939

Review 4.  The complex and evolving story of T cell activation to AAV vector-encoded transgene products.

Authors:  Lauren E Mays; James M Wilson
Journal:  Mol Ther       Date:  2010-11-30       Impact factor: 11.454

5.  Regulatory T cells and their role in rheumatic diseases: a potential target for novel therapeutic development.

Authors:  Diana Milojevic; Khoa D Nguyen; Diane Wara; Elizabeth D Mellins
Journal:  Pediatr Rheumatol Online J       Date:  2008-12-01       Impact factor: 3.054

6.  New insights into immunomodulation via overexpressing lipoic acid synthase as a therapeutic potential to reduce atherosclerosis.

Authors:  Shaomin Tian; Jun Nakamura; Sylvia Hiller; Stephen Simington; Darcy W Holley; Roberto Mota; Monte S Willis; Scott J Bultman; J Christopher Luft; Joseph M DeSimone; Zhenquan Jia; Nobuyo Maeda; Xianwen Yi
Journal:  Vascul Pharmacol       Date:  2020-08-01       Impact factor: 5.773

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.